HBOT Evidence Digest · Pacific Hyperbarics
Carbon Monoxide Poisoning
FDA status
Recognized
Evidence
Grade A · Strong
Coverage
Medicare ✓
ICD-10
T58.11XA
Summary
HBOT rapidly clears carbon monoxide from the blood and reduces the risk of delayed neurological injury.
Typical protocol
2.8–3.0 ATA × 90–120 min, ASAP, up to 3 in 24h, 1–3 sessions · UHMS
The evidence (2)
-
[1] Hyperbaric oxygen for carbon monoxide poisoning (Cochrane review)
MIXEDBuckley NA, Juurlink DN, Isbister G, et al. · Cochrane Database of Systematic Reviews · 2011 · PMID 21491385
Reviewing seven trials with conflicting results, the authors concluded existing evidence neither firmly establishes nor excludes benefit, reflecting the ongoing clinical debate.
Quality: Highlights heterogeneity across CO trials.
-
[2] Hyperbaric oxygen for acute carbon monoxide poisoning
POSITIVEWeaver LK, Hopkins RO, Chan KJ, et al. · New England Journal of Medicine · 2002 · n=152 · PMID 12362006
Randomized trial in which three HBOT sessions reduced the rate of cognitive sequelae at 6 weeks after acute CO poisoning compared with normobaric oxygen.
Quality: Landmark NEJM RCT; basis for HBOT in CO poisoning with neurological risk.